Lärkberget AB (publ) (STO:LARK)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.370
-0.010 (-0.42%)
At close: Aug 7, 2025
-0.42%
Market Cap46.93M
Revenue (ttm)2.00M
Net Income (ttm)-44.88M
Shares Out19.80M
EPS (ttm)-2.27
PE Ration/a
Forward PEn/a
Dividend0.20 (8.40%)
Ex-Dividend DateJun 13, 2025
Volume1,767
Average Volume78,626
Open2.310
Previous Close2.380
Day's Range2.310 - 2.400
52-Week Range1.270 - 3.060
Beta1.23
RSI50.49
Earnings DateAug 22, 2025

About Theseus Pharmaceuticals

Lärkberget AB (publ) operates as an investment company. It is involved in Direct investments in low-risk instruments; Financial investments; Direct investments in unlisted profitable companies; and Reverse acquisition platform. The company was formerly known as CombiGene AB (publ) and changed its name to Lärkberget AB (publ) in June 2025. Lärkberget AB (publ) was incorporated in 1990 and is based in Östermalm, Sweden. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1990
Employees 9
Stock Exchange Nasdaq Stockholm
Ticker Symbol LARK
Full Company Profile

Financial Performance

In 2024, Lärkberget AB's revenue was 2.00 million, a decrease of -71.47% compared to the previous year's 7.01 million. Losses were -44.88 million, 25.8% more than in 2023.

Financial Statements

News

There is no news available yet.